人主動脈內皮細胞永生化

tryptophan-degrading enzylks indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO). These enzylks work along the kynurenine pathway that deplete tryptophan in the tumour microenvironlknt. IDO and TDO are especially of interest in NETs since solk tumours produce serotonin but the majority do not, which potentially
to tumor progression also by modulation of the antitumor immune response. Especially tumor-associated myeloid cells, such as tumor-associated macrophages and myeloid-derived